- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adicet Bio Inc (ACET)
Track the Adicet Bio share price today and view real-time ACET share price data, including charts, technicals, and key financials. View the ACET premarket stock price ahead of the market session or assess the after hours quote. Explore ACET stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Adicet Bio Stock Price Today?
The Adicet Bio stock price today is 8.570.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is ""ACET.""
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio a Good Stock to Buy?
Determining whether Adicet Bio or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070022076)
What Is the Adicet Bio Stock Price Today?
The Adicet Bio stock price today is 8.570.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is ""ACET.""
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the NASDAQ stock exchange.
Is Adicet Bio a Good Stock to Buy?
Determining whether Adicet Bio or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACET quote. (ISIN: US0070022076)
NASDAQ
Currency in USD
8.570
+0.060(+0.71%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.510
8.759
52 wk Range
6.010
17.438
ACET is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.5108.759
52 wk Range
6.01017.438
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACET Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
34.833
Upside
+306.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Form 13D/A Adicet Bio For: 10 April
- Investing.com
- Form 13G Adicet Bio For: 13 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 34.833
(+306.46% Upside)
Adicet Bio Inc SWOT Analysis
Gamma-Delta Pionee | Adicet Bio leads in engineered gamma-delta T cell therapies, with promising candidates for lupus nephritis and renal cell carcinoma in Phase 1 trials |
Financial Fortitude | Strong cash position of $150.4M supports ongoing clinical trials, though rapid cash burn rate poses future funding challenges |
Expanding Horizons | Explore Adicet's ambitious pipeline expansion into multiple autoimmune conditions, showcasing the versatility of its innovative platform |
Market Valuation | With analyst price targets ranging from $4 to $8 per share, Adicet's current trading price of $0.69 presents a potential asymmetric upside opportunity |
Earnings
Latest Release
05/03/2026
EPS / Forecast
-2.84 / -0.19
Revenue / Forecast
-- / 2.5M
Compare ACET to Peers and Sector
Metrics to compare | ACET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACETPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.0x | −0.5x | |
PEG Ratio | −0.04 | −0.20 | 0.00 | |
Price/Book | 0.6x | 2.5x | 2.6x | |
Price / LTM Sales | - | 6.0x | 3.2x | |
Upside (Analyst Target) | 164.4% | 259.9% | 47.8% | |
Fair Value Upside | Unlock | 11.3% | 5.9% | Unlock |
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company’s lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Adicet Bio (ACET) Stock Price Today?
The Adicet Bio stock price today is 8.570 USD.
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is "ACET."
What Is the Adicet Bio Market Cap?
As of today, Adicet Bio market cap is 92.660M USD.
What Is Adicet Bio's Earnings Per Share (TTM)?
The Adicet Bio EPS (TTM) is -16.949.
When Is the Next Adicet Bio Earnings Date?
Adicet Bio will release its next earnings report on 05/03/2026.
From a Technical Analysis Perspective, Is ACET a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Adicet Bio Stock Split?
Adicet Bio has split 2 times.
How Many Employees Does Adicet Bio Have?
Adicet Bio has 102 employees.
What is the current trading status of Adicet Bio (ACET)?
As of 06/05/2026, Adicet Bio (ACET) is trading at a price of 8.570 USD, with a previous close of 8.510 USD. The stock has fluctuated within a day range of 8.510 USD to 8.759 USD, while its 52-week range spans from 6.010 USD to 17.438 USD.
What Is Adicet Bio (ACET) Price Target According to Analysts?
The average 12-month price target for Adicet Bio is 34.833 USD, with a high estimate of 100 USD and a low estimate of 18 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +306.46% Upside potential.
What Is the ACET Premarket Price?
ACET's last pre-market stock price is 8.530 USD. The pre-market share volume is 792.000, and the stock has decreased by 0.020, or 0.240%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.